ATE363913T1 - Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis - Google Patents

Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis

Info

Publication number
ATE363913T1
ATE363913T1 AT99909244T AT99909244T ATE363913T1 AT E363913 T1 ATE363913 T1 AT E363913T1 AT 99909244 T AT99909244 T AT 99909244T AT 99909244 T AT99909244 T AT 99909244T AT E363913 T1 ATE363913 T1 AT E363913T1
Authority
AT
Austria
Prior art keywords
tcf
sepsis
preventives
treat
remedies
Prior art date
Application number
AT99909244T
Other languages
English (en)
Inventor
Tohru Tani
Hiroyuki Kondo
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE363913T1 publication Critical patent/ATE363913T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Water Treatment By Sorption (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99909244T 1998-03-19 1999-03-19 Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis ATE363913T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10070914A JPH11269091A (ja) 1998-03-19 1998-03-19 敗血症予防及び/又は治療剤

Publications (1)

Publication Number Publication Date
ATE363913T1 true ATE363913T1 (de) 2007-06-15

Family

ID=13445266

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99909244T ATE363913T1 (de) 1998-03-19 1999-03-19 Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis

Country Status (13)

Country Link
US (1) US20060251615A1 (de)
EP (1) EP0982037B1 (de)
JP (1) JPH11269091A (de)
KR (1) KR100572044B1 (de)
AT (1) ATE363913T1 (de)
AU (1) AU753198B2 (de)
CA (1) CA2288881A1 (de)
DE (1) DE69936248T2 (de)
DK (1) DK0982037T3 (de)
ES (1) ES2288014T3 (de)
TW (1) TW518229B (de)
WO (1) WO1999047155A1 (de)
ZA (1) ZA997352B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4006058B2 (ja) 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び/又は治療剤
US20020041863A1 (en) 1997-03-14 2002-04-11 Masamichi Kojiro Preventive and/or therapeutic agent for cachexia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
ATE159171T1 (de) * 1992-07-16 1997-11-15 Snow Brand Milk Products Co Ltd Arzneimittelzusammensetzung enthaltend tcf-ii
KR100260964B1 (ko) * 1992-07-16 2000-07-01 쇼노 카츄야 Tcf-ii를 유효성분으로 하는 혈액응고 정상화제

Also Published As

Publication number Publication date
EP0982037B1 (de) 2007-06-06
ES2288014T3 (es) 2007-12-16
DE69936248D1 (de) 2007-07-19
DE69936248T2 (de) 2008-01-31
AU753198B2 (en) 2002-10-10
ZA997352B (en) 2000-05-29
WO1999047155A1 (fr) 1999-09-23
JPH11269091A (ja) 1999-10-05
US20060251615A1 (en) 2006-11-09
KR20010012687A (ko) 2001-02-26
EP0982037A1 (de) 2000-03-01
EP0982037A4 (de) 2004-10-13
CA2288881A1 (en) 1999-09-23
AU2853699A (en) 1999-10-11
TW518229B (en) 2003-01-21
KR100572044B1 (ko) 2006-04-17
DK0982037T3 (da) 2007-10-08

Similar Documents

Publication Publication Date Title
AU747599C (en) Antitumor agents
TR200102020T2 (tr) Raf kinaz inhibitörleri olarak w-karboksiaril sübstitüe edilmiş difenil üreler.
EA200600618A1 (ru) Применение эффекторов глутаминил- и глутаматциклаз
YU21401A (sh) Tetrahidropiridoetri
DE59903921D1 (de) Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
TR200100874T2 (tr) Simetrik ve simetrik olmayan sübstitüe edilmiş difenil üreler kullanılarak raf kinazın inhibe edilmesi
TR200200883T2 (tr) 2-ikameli 1,1-bifenil-2-karbonamidler, imalat yöntemleri, ilaç olarak kullanılmaları
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
DK1149910T3 (da) Farmaceutisk præparat til behandling af papillomavirustumorer og -infektion
ATE386742T1 (de) Imidazonaphthyridine
WO2003017939A3 (en) Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
ATE265455T1 (de) Tetrahydropyridoverbindungen
ATE222119T1 (de) Verwendung von erythropoietin zur behandlung von multiple myelom
PT1140113E (pt) Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE69936248D1 (de) Verwendung von tcf-ii zur behandlung oder vorbeugung von sepsis
DE60035133D1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
DE3784768D1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.
TR200200987T2 (tr) Kanser tedavisine yönelik,ornatılmış pirroller
JPS5217946A (en) Underlay for shoes sterilized by copper
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
MX9602407A (es) Composiciones farmaceuticas.
ATE86863T1 (de) Verwendung von zusammensetzungen auf basis von crotoxin, zur herstellung von medikamenten zur behandlung von carcinomen.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification

Ref document number: 0982037

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee